What Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros' (BME:LDA) P/S Is Not Telling You

It's not a stretch to say that Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros' (BME:LDA) price-to-sales (or "P/S") ratio of 1.2x right now seems quite "middle-of-the-road" for companies in the Insurance industry in Spain, where the median P/S ratio is around 1x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.

View our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros

ps-multiple-vs-industry
BME:LDA Price to Sales Ratio vs Industry September 3rd 2024
Advertisement

What Does Línea Directa Aseguradora Compañía de Seguros y Reaseguros' P/S Mean For Shareholders?

With revenue growth that's inferior to most other companies of late, Línea Directa Aseguradora Compañía de Seguros y Reaseguros has been relatively sluggish. It might be that many expect the uninspiring revenue performance to strengthen positively, which has kept the P/S ratio from falling. You'd really hope so, otherwise you're paying a relatively elevated price for a company with this sort of growth profile.

Want the full picture on analyst estimates for the company? Then our free report on Línea Directa Aseguradora Compañía de Seguros y Reaseguros will help you uncover what's on the horizon.

Is There Some Revenue Growth Forecasted For Línea Directa Aseguradora Compañía de Seguros y Reaseguros?

Línea Directa Aseguradora Compañía de Seguros y Reaseguros' P/S ratio would be typical for a company that's only expected to deliver moderate growth, and importantly, perform in line with the industry.

If we review the last year of revenue growth, the company posted a worthy increase of 5.8%. Revenue has also lifted 11% in aggregate from three years ago, partly thanks to the last 12 months of growth. So we can start by confirming that the company has actually done a good job of growing revenue over that time.

Looking ahead now, revenue is anticipated to climb by 4.3% each year during the coming three years according to the five analysts following the company. That's shaping up to be materially lower than the 7.2% each year growth forecast for the broader industry.

In light of this, it's curious that Línea Directa Aseguradora Compañía de Seguros y Reaseguros' P/S sits in line with the majority of other companies. Apparently many investors in the company are less bearish than analysts indicate and aren't willing to let go of their stock right now. These shareholders may be setting themselves up for future disappointment if the P/S falls to levels more in line with the growth outlook.

The Final Word

While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.

When you consider that Línea Directa Aseguradora Compañía de Seguros y Reaseguros' revenue growth estimates are fairly muted compared to the broader industry, it's easy to see why we consider it unexpected to be trading at its current P/S ratio. When we see companies with a relatively weaker revenue outlook compared to the industry, we suspect the share price is at risk of declining, sending the moderate P/S lower. This places shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.

We don't want to rain on the parade too much, but we did also find 1 warning sign for Línea Directa Aseguradora Compañía de Seguros y Reaseguros that you need to be mindful of.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

Berkshire sold Visa and Mastercard. Ackman just bought both. So whose "smart money" are you actually following?

106
Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About BME:LDA

Línea Directa Aseguradora Compañía de Seguros y Reaseguros

Engages in insurance and reinsurance business in Spain and Portugal.

Solid track record with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.1% undervalued
45 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
AN
andrei9868
Emerging Author
NOW logo
andrei9868 on ServiceNow ·

The Platform Turning Enterprise Chaos into Autonomous Workflows

Fair Value:US$17012.9% undervalued
11 users have followed this narrative
2 users have commented on this narrative
2 users have liked this narrative
JO
John_Eric
Emerging Author
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8752.9% undervalued
5 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
HA
HarishPK
Emerging Author
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$36.0929.5% undervalued
4 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

LU
LunaRodas
MDT logo
LunaRodas on Medtronic ·

MDT | Medtronic: What They Said vs. What They Did

Fair Value:US$115.3821.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MO
7010 logo
Mohammed_Ahmed_Aleen on Saudi Telecom ·

Could LEAP 2026 Make stc Worth SAR 46.50 Per Share?

Fair Value:ر.س46.494.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TI
SBS logo
TimLee on SBS Nexus Berhad ·

SBS Nexus Delivers Strong Q2 Profit Rebound as Digital Branding Drives Growth

Fair Value:RM 0.3560.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28021.2% undervalued
372 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.5% undervalued
128 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.8% overvalued
217 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative